Novavax vaccine claims to be 90% effective against Covid-19

Novavax said its vaccine demonstrated 100% protection against moderate and severe disease, 90.4% overall efficacy, and met the primary endpoint of its pivotal phase 3 PREVENT-19 trial. United States: Biotech company Novavax said on Monday that its Covid-19 vaccine is highly effective against COVID-19 in a large study and also protects against variants. In an …

Novavax vaccine claims to be 90% effective against Covid-19 Read More »